BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18449850)

  • 1. Polydrug use, cannabis, and psychosis-like symptoms.
    Van Dam NT; Earleywine M; DiGiacomo G
    Hum Psychopharmacol; 2008 Aug; 23(6):475-85. PubMed ID: 18449850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM; Parrott AC; Schifano F; Turner JJ
    Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis use correlates with schizotypy in healthy people.
    Williams JH; Wellman NA; Rawlins JN
    Addiction; 1996 Jun; 91(6):869-77. PubMed ID: 8696249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cannabis and psychoses].
    Kristensen FW
    Ugeskr Laeger; 1994 May; 156(19):2875-8, 2881. PubMed ID: 8009723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms of schizotypy precede cannabis use.
    Schiffman J; Nakamura B; Earleywine M; LaBrie J
    Psychiatry Res; 2005 Mar; 134(1):37-42. PubMed ID: 15808288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability.
    Zimmermann P; Wittchen HU; Waszak F; Nocon A; Höfler M; Lieb R
    Drug Alcohol Depend; 2005 Sep; 79(3):331-41. PubMed ID: 15913921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis 'tinny' houses in New Zealand: implications for the use and sale of cannabis and other illicit drugs in New Zealand.
    Wilkins C; Reilly JL; Casswell S
    Addiction; 2005 Jul; 100(7):971-80. PubMed ID: 15955013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychosis and cannabis consumption: study of the psychopathologic differences and risk factors].
    Crespo MD; Morales MP; Viñas R; Ríos B; Ruiz L; Franco B
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1990; 18(2):120-4. PubMed ID: 2368637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users.
    Milani RM; Parrott AC; Turner JJ; Fox HC
    Addict Behav; 2004 Jul; 29(5):965-71. PubMed ID: 15219343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmedical drug use among stimulant-using adults in small towns in rural Ohio.
    Falck RS; Siegal HA; Wang J; Carlson RG; Draus PJ
    J Subst Abuse Treat; 2005 Jun; 28(4):341-9. PubMed ID: 15925268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Schizoid psychosis during cannabis intake (case report)].
    Gaszner P; Csernus I; Fülöp B; Gaszner G
    Neuropsychopharmacol Hung; 2004 Jun; 6(2):90-2. PubMed ID: 15787208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personality dimensions and psychopathological profiles of Ecstasy users.
    Dughiero G; Schifano F; Forza G
    Hum Psychopharmacol; 2001 Dec; 16(8):635-639. PubMed ID: 12404544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulsivity, inhibition and negative priming in ecstasy users.
    Dafters RI
    Addict Behav; 2006 Aug; 31(8):1436-41. PubMed ID: 16242244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis.
    Fergusson DM; Boden JM; Horwood LJ
    Addiction; 2006 Apr; 101(4):556-69. PubMed ID: 16548935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of disorders after chronic psychoactive drug abuse in patients hospitalized in detoxification units].
    Chrostek Maj J; Kroch S; Kamenczak A; Polewka A; Szerszeń-Motyka J
    Przegl Lek; 2004; 61(4):317-9. PubMed ID: 15521592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cannabis and psychosis connection questioned: a comment on Fergusson et al. 2005.
    Mirken B; Earleywine M
    Addiction; 2005 May; 100(5):714-5; author reply 715-6. PubMed ID: 15847630
    [No Abstract]   [Full Text] [Related]  

  • 17. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs.
    Hall WD; Lynskey M
    Drug Alcohol Rev; 2005 Jan; 24(1):39-48. PubMed ID: 16191720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marijuana. Health and treatment issues.
    Jones RT
    Psychiatr Clin North Am; 1984 Dec; 7(4):703-12. PubMed ID: 6097886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On psychiatric syndromes associated with cannabis.
    Hart RH
    Ala Med; 1984 Aug; 54(2):34-6. PubMed ID: 6332510
    [No Abstract]   [Full Text] [Related]  

  • 20. 'Cannabis-induced psychosis' may obscure paranoid schizophrenia.
    Saxena S
    Natl Med J India; 1993; 6(2):78-9. PubMed ID: 8477216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.